Mounjaro 5mg (tirzepatide)

Mounjaro (tirzepatide) 5 mg is a prescription injection designed to treat adults with type 2 diabetes. As a dual GLP-1 and GIP receptor agonist, it enhances insulin release, reduces liver glucose production, and slows gastric emptying. The 5 mg dose is usually prescribed after the initial 2.5 mg dose, allowing for better blood sugar control and potential weight loss benefits. When combined with diet and physical activity, Mounjaro 5 mg helps reduce HbA1c levels and maintain long-term metabolic health.